Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuroimaging Markers of Midlife Depression and Cognitive Behavioural Therapy (CBT)

NCT07091643 is registered in ClinicalTrials.gov with Baycrest as lead sponsor.

NCT NCT07091643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07091643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuroimaging Markers of Midlife Depression and Cognitive Behavioural Therapy (CBT)
Lead sponsor
Baycrest
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 30, 2026
Completion date
December 31, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder (mdd)